In this final (honorary) sit-down from the JP Morgan Chase Healthcare Conference in San Francisco last month, pharmaphorum editor-in-chief Jonah Comstock chats virtually with Joe Spinelli, SVP prod
In our penultimate JP Morgan 2023 interview, pharmaphorum editor-in-chief Jonah Comstock caught up with Lisa Yañez, CEO of Aerami Therapeutics, at the Fairmont Hotel.
In San Francisco in January for JP Morgan, editor-in-chief Jonah Comstock sat down at the Hotel Spero with Stefan Weber and Ravi Anand, CEO and CMO, respectively, of neurology-focused biotech Newro
On Wednesday of JP Morgan week last month, pharmaphorum editor-in-chief Jonah Comstock sat down at the Zeppelin Hotel with Claudia Ulbrich, CEO of Germany-based Cardior, to learn a little more abou
In an industry growing as quickly as cell therapy, keeping up with the demands of manufacturing and treatment is a challenge for the whole industry to tackle together, including stakeholder
Drug discovery is usually a goal-driven and iterative process, as researchers look for innovative new routes to target particular diseases and study those diseases in afflicted patients to learn ho